Measurement of patient compliance and the interpretation of randomized clinical trials.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 1838332
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Results of the PAS urine test (phenistix) study done in May and June, 1959.

  2015cited by this paper
• The Problem of Non-compliance with Drug Therapy

  2012cited by this paper
• Methods in assessing drug compliance.

  2009cited by this paper
• Patient report validated against prescription records for measuring use of and compliance with antihypertensive drugs.

  2009cited by this paper
• Use of a pharmacological indicator to monitor compliance with thyroxine

  2004cited by this paper
• Adverse drug reactions and drug non-compliance as primary causes of admission to a cardiology department

  2004cited by this paper
• Pill hoarding and hypercompliance

  1990cited by this paper
• Monitoring compliance in clinical trials.

  1990cited by this paper
• Compliance with short-term high-dose ethinyl oestradiol in young patients with primary infertility. New insights from the use of electronic devices.

  1990cited by this paper
• Poor Compliance Is a Major Factor in Unstable Outpatient Control of Anticoagulant Therapy

  1989cited by this paper
• The benefits of prescription information leaflets (1).

  1989cited by this paper
• How often is medication taken as prescribed? A novel assessment technique.

  1989cited by this paper
• Deuterium oxide as a tracer for measurement of compliance in pediatric clinical drug trials.

  1989cited by this paper
• The natural history of medication compliance in a drug trial: Limitations of pill counts

  1989cited by this paper
• Time to stop counting the tablets?

  1989cited by this paper
• The benefits of prescription information leaflets (2).

  1989cited by this paper
• Factorial designs in clinical trials: the effects of non-compliance and subadditivity.

  1989cited by this paper
• How useful is riboflavin as a tracer of medication compliance?

  1989cited by this paper
• Precipitating factors leading to decompensation of heart failure. Traits among urban blacks.

  1988cited by this paper
• Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily

  1988cited by this paper
• Can categorization of patient background problems be used to determine early termination in a clinical trial?

  1988cited by this paper
• Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants.

  1988cited by this paper
• Pill count measures of compliance in a drug trial: variability and suitability.

  1988cited by this paper
• Recurrent tuberculosis: why do patients develop disease again? A United States Public Health Service cooperative survey.

  1988cited by this paper
• Drug‐Associated Hospital Admissions in Older Medical Patients

  1988cited by this paper
• A Comparative Trial of Digoxin and Digitoxin in the Treatment of Congestive Heart Failure

  1988cited by this paper
• The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy.

  1988cited by this paper
• The paradox of using a 7 day antibacterial course to treat urinary tract infections in the community.

  1988cited by this paper
• A General Method of Compliance Assessment Using Centralized Pharmacy Records: Description and Validation

  1988cited by this paper
• Compliance in clinical trials: impact on design, analysis and interpretation.

  1988cited by this paper
• Elders' Nonadherence, Its Assessment, and Computer Assisted Instruction for Medication Recall Training

  1988cited by this paper
• Low-dose phenobarbitone as an indicator of compliance with drug therapy.

  1987cited by this paper
• Chronic illness and compliance.

  1987cited by this paper
• Minimal doses of digoxin: a new marker for compliance to medication.

  1987cited by this paper
• Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial.

  1987cited by this paper
• Patient compliance and the conduct and interpretation of therapeutic trials.

  1987cited by this paper
• Monitoring medication compliance: description of a new device.

  1987cited by this paper
• Compliance with topical timolol treatment.

  1987cited by this paper
• Sample size determination in clinical trials with time-dependent rates of losses and noncompliance.

  1986cited by this paper
• Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?

  1986cited by this paper
• Compliance with topical pilocarpine treatment.

  1986cited by this paper
• Measurement of compliance.

  1985cited by this paper
• Compliance in hypertension: facts and concepts.

  1985cited by this paper
• Patient adherence to prescribed therapies.

  1985cited by this paper
• Riboflavin as a tracer of medication compliance

  1985cited by this paper
• Doctor-patient communication: some quantitative estimates of the role of cognitive factors in non-compliance.

  1985cited by this paper
• Compliance: the case for objective measurement.

  1985cited by this paper
• The role of theory in the study of adherence to treatment and doctor-patient interactions.

  1985cited by this paper
• Problems and prospects for health services research on provider-patient communication.

  1985cited by this paper
• Issues in medication adherence assessment in clinical trials of the National Heart, Lung, and Blood Institute.

  1984cited by this paper
• The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

  1984cited by this paper
• Behavioral aspects of the use of medical markers in clinical trials.

  1984cited by this paper
• Proceedings of the workshop on the development of markers for use as adherence measures in clinical studies. May 24-25, 1982.

  1984cited by this paper
• The statistical analysis of adherence data obtained from markers.

  1984cited by this paper
• Chemical analysis of marker substances.

  1984cited by this paper
• Stable isotopic abundances as reflections of ingestion practices.

  1984cited by this paper
• Statement of the problem and pharmacological and clinical requirements for the ideal marker.

  1984cited by this paper
• Tracer microspheres as compliance markers in clinical research.

  1984cited by this paper
• Alternative adherence marker schemes.

  1984cited by this paper
• Adherence measures and their utility.

  1984cited by this paper
• Riboflavin, self-report, and serum norethindrone. Comparison of their use as indicators of adolescent compliance with oral contraceptives.

  1984cited by this paper
• The direct effects of compliance on health outcome.

  1984cited by this paper
• Riboflavin use as a drug marker in Veterans Administration cooperative studies.

  1984cited by this paper
• Clinical pharmacology of a marker of patient compulsiveness.

  1984cited by this paper
• Use of stable isotopes to determine compliance.

  1984cited by this paper
• Participants in Noncompliance Research: Compliant or Noncompliant?

  1982cited by this paper
• Maintenance of the antihypertensive efficacy of captopril despite consistent reduction in daily dosage.

  1982cited by this paper
• Satisfaction, compliance and communication.

  1982cited by this paper
• Management of patient compliance in the treatment of hypertension. Report of the NHLBI Working Group.

  1982cited by this paper
• Medical admissions due to noncompliance with drug therapy.

  1982cited by this paper
• Nondichotomous patterns of medication usage: The yes‐no fallacy

  1982cited by this paper
• Methodological rigor and citation frequency in patient compliance literature.

  1982cited by this paper
• Accuracy of patient interviews and estimates by clinical staff in determining medication compliance.

  1981cited by this paper
• Assessing clinical trials--trial discipline.

  1981cited by this paper
• A MEDICATION MONITOR AND FLUORESCEIN TECHNIQUE DESIGNED TO STUDY MEDICATION BEHAVIOUR

  1980cited by this paper
• Planning the size of a cohort study in the presence of both losses to follow-up and non-compliance.

  1980cited by this paper
• The pill bottle desiccant and noncompliance.

  1980cited by this paper
• Variations in Patient Compliance with Common Long-Term Drugs

  1980cited by this paper
• The unrealized potential of the medication monitor

  1979cited by this paper
• In search of the gold standard for compliance measurement.

  1979cited by this paper
• Memory for medical information.

  1979cited by this paper
• Accuracy of doctors' estimates and patients' statements on adherence to a drug regimen

  1978cited by this paper
• Dose response to chlorthalidone in patients with mild hypertension; Efficacy of a lower dose

  1978cited by this paper
• Behavioral control of medicine compliance.

  1978cited by this paper
• Medication monitor for ophthalmology.

  1974cited by this paper
• Drug defaulting. II. Analysis of noncompliance patterns.

  1974cited by this paper
• Drug defaulting. I. Determinants of compliance.

  1974cited by this paper
• Patient compliance assessment in drug trials: usage and methods.

  1974cited by this paper
• Letter: Self-administration of isoniazid and thiacetazone studied by medication monitoring.

  1974cited by this paper
• DifFerences in serum digoxin concentrations between outpatients and inpatients: An effect of compliance?

  1974cited by this paper
• Diagnosis and management of patient noncompliance.

  1974cited by this paper
• Drug therapy: patient compliance.

  1973cited by this paper
• A review of medication errors and compliance in ambulant patients

  1972cited by this paper
• The drug defaulter

  1972cited by this paper
• The use of a drug marker in a clinical trial.

  1971cited by this paper
• Assessment of dosage deviation in outpatient drug research.

  1970cited by this paper
• Measuring intake of a prescribed medication A bottle count and a tracer technique compared

  1970cited by this paper
• Drug Defaulting in a General Practice*

  1969cited by this paper
• The Inaccuracy in Using Interviews to Estimate Patient Reliability in Taking Medications at Home

  1969cited by this paper
• Patients' cooperation with a medical regimen. Difficulties in identifying the noncooperator.

  1968cited by this paper

• Evaluation, analysis, and reporting of medication adherence for clinical trials of anticoagulants in children: Guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis.

  2024cites this paper
• Statistical methods for handling compliance in randomised controlled trials of device interventions: a systematic review.

  2022cites this paper
• Novel Tool to Monitor Adherence to Oral Oncolytics: A Pilot Study.

  2021cites this paper
• Adherence trajectories in oral therapy for chronic myeloid leukemia: Overview of a research protocol.

  2020cites this paper
• Treatment of elderly patients with refractory/relapsed multiple myeloma: oral drugs adherence and the COVID-19 outbreak

  2020cites this paper
• Efficacy and safety of Onkyeong-tang in treating cold hypersensitivity in the feet of Korean women: protocol for a double-blind, randomized, placebo-controlled, parallel-group, multicenter clinical study

  2020cites this paper
• Patient adherence to antihypertensive medications in upper Egypt: a cross-sectional study

  2020cites this paper
• Impact of hospitalization on medication adherence estimation in claims data

  2017cites this paper
• The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial.

  2017cites this paper
• The effects of non-adherence on health care utilisation:panel data evidence on uncontrolled diabetes

  2016cites this paper
• Mitigating the Effects of Nonadherence in Clinical Trials

  2016cites this paper
• Optimizing early child development for young children with non-anemic iron deficiency in the primary care practice setting (OptEC): study protocol for a randomized controlled trial

  2015cites this paper
• An internal pilot study for a randomized trial aimed at evaluating the effectiveness of iron interventions in children with non-anemic iron deficiency: the OptEC trial

  2015cites this paper
• Pregabalin and pain after total knee arthroplasty: a double-blind, randomized, placebo-controlled, multidose trial.

  2015cites this paper
• Adherence to preventive medications in asthmatic children at a tertiary care teaching hospital in Malaysia

  2014cites this paper
• Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.

  2013cites this paper
• Adherence to treatment is a complex and multifaceted issue that can substantially alter the outcome of chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.

  2012cites this paper
• The effect of reminder systems on patients’ adherence to treatment

  2012cites this paper
• Imatinib treatment in chronic myelogenous leukemia: What have we learned so far?

  2011cites this paper
• Treatment non-adherence in teenage and young adult patients with cancer.

  2011cites this paper
• Self-Reported Compliance with Capecitabine: Findings from a Prospective Cohort Analysis

  2011cites this paper
• Fish consumption among young overweight European adults and compliance to varying seafood content in four weight loss intervention diets

  2009cites this paper
• Systematic Review: Safety and Efficacy of Extended-Duration Antiviral Chemoprophylaxis Against Pandemic and Seasonal Influenza

  2009cites this paper
• Patient adherence and persistence with oral anticancer treatment

  2009cites this paper
• Antihypertensive drug medication adherence and its affecting factors in South Korea.

  2008cites this paper
• A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes.

  2007cites this paper
• Patient compliance in hypertension from measurement to improvement

  2006cites this paper
• Detection of Non-Adherent Behaviour in Early Psychosis

  2006cites this paper
• Detection of non-adherent behaviour in early psychosis.

  2006cites this paper
• Terapia hipotensyjna a przestrzeganie zaleceń Antihypertensive therapy and compliance Summary

  2005cites this paper
• Assessing adherence with toothbrushing instructions using a data logger toothbrush

  2005cites this paper
• Enhancing adherence in clinical research.

  2005cites this paper
• Noncompliance in cardiovascular clinical trials.

  2005cites this paper
• How Much Compliance Is Enough?

  2004cites this paper
• Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review

  2004cites this paper
• Effects of exogenous growth hormone on resting pulmonary function in children with thermal injury.

  2004cites this paper
• [Compliance in HIV infected adults. Study of opportunistic infection prophylaxis with cotrimoxazole in Ivory Coast].

  2004cites this paper
• Measuring Adherence in a Hypertension Clinical Trial

  2003cites this paper
• Comparison of self-reported and monitored compliance of daily injection of human growth hormone in burned children.

  2003cites this paper
• Determinants of dropout in a community intervention trial on the caries-preventive effect of chewing gums.

  2002cites this paper
• Adherence to therapy with oral antineoplastic agents.

  2002cites this paper
• A Comparison of Three Different Sleep Schedules for Reducing Daytime Sleepiness in Narcolepsy SLEEPINESS

  2001cites this paper
• The natural history of azathioprine compliance after renal transplantation.

  2001cites this paper
• A comparison of three different sleep schedules for reducing daytime sleepiness in narcolepsy.

  2001cites this paper
• Patient adherence to treatment: three decades of research. A comprehensive review

  2001cites this paper
• Treatment Strategy to Control Blood Pressure Optimally in Hypertensive Patients

  2001cites this paper
• Ethics in adherence promotion and monitoring.

  2000cites this paper
• How to improve adherence with prescribed treatment in hypertensive patients?

  2000cites this paper
• The impact of compliance in pharmacokinetic studies

  1999cites this paper
• The ExACT CM Microprocessor-Based Compliance Recording Device: Product Description and Field Testing Results

  1999cites this paper
• Compliance with antihypertensive therapy.

  1999cites this paper
• Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens.

  1998cites this paper
• Drug compliance in therapeutic trials: a review.

  1998cites this paper
• Comparison of three composite compliance indices in a trial of self-administered preventive therapy for tuberculosis in HIV-infected Ugandan adults. Uganda-Case Western Reserve University Research Collaboration.

  1998cites this paper
• Characterizing patterns of drug‐taking behavior with a multiple drug regimen in an AIDS clinical trial

  1998cites this paper
• The extent of non‐adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker

  1998cites this paper
• Drug compliance in pediatrics. Clinical and research issues.

  1997cites this paper
• Self-reported medication non-compliance in the elderly

  1997cites this paper
• Rationale, objectives, and interpretation of randomized controlled trials

  1997cites this paper
• Compliance with stimulant medications in patients with narcolepsy.

  1997cites this paper
• Medication compliance as a feature in drug development.

  1997cites this paper
• The assessment of refill compliance using pharmacy records: methods, validity, and applications.

  1997cites this paper
• Facilitated analysis of data on drug regimen compliance.

  1997cites this paper
• Patient compliance with crucial drug regimens: implications for prostate cancer.

  1996cites this paper
• Measuring Transplant Patients' Compliance with Immunosuppressive Therapy

  1996cites this paper
• Compliance monitoring of NSAID drug therapy in ankylosing spondylitis, experiences with an electronic monitoring device.

  1996cites this paper
• Do we need full compliance data for population pharmacokinetic analysis?

  1996cites this paper
• Factors Influencing Post‐Menopausal African‐American Women’s Participation in a Clinical Trial

  1995cites this paper
• Dose Frequency and Dose Interval Compliance with Multiple Antiepileptic Medications During a Controlled Clinical Trial

  1995cites this paper
• Comprehensive geriatric assessment and medication compliance.

  1995cites this paper
• Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertension. The Belgian Collaborative Study Group.

  1995cites this paper
• Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care.

  1994cites this paper
• Patient Compliance and Therapeutic Coverage: Amlodipine versus Nifedipine (Slow-Release) in the Treatment of Angina Pectoris

  1994cites this paper
• Role of patient compliance in clinical pharmacokinetics. A review of recent research.

  1994cites this paper
• Variable patient compliance in ambulatory trials--nuisance, threat, opportunity.

  1993cites this paper
• The Bayer Compliance Device

  1993cites this paper
• Achieving Investigator Compliance

  1993cites this paper
• Measurement of Drug Compliance by Continuous Electronic Monitoring: A Pilot Study in Elderly Patients Discharged From Hospital

  1992cites this paper
• Patient compliance with drug treatment — new perspectives on an old problem

  1992cites this paper